Hemangio Pericytoma of the Nasal Cavity
Published: 2021-04-06
Page: 254-258
Issue: 2021 - Volume 4 [Issue 1]
A. Raihane *
Department of ENT Head and Neck Surgery, Faculty of Medicine and Pharmacy, Ibn Rochd University Hospital, Hassan II University, Casablanca, Morocco.
Y. Oukessou
Department of ENT Head and Neck Surgery, Faculty of Medicine and Pharmacy, Ibn Rochd University Hospital, Hassan II University, Casablanca, Morocco.
S. Rouadi
Department of ENT Head and Neck Surgery, Faculty of Medicine and Pharmacy, Ibn Rochd University Hospital, Hassan II University, Casablanca, Morocco.
R. Abada
Department of ENT Head and Neck Surgery, Faculty of Medicine and Pharmacy, Ibn Rochd University Hospital, Hassan II University, Casablanca, Morocco.
M. Roubal
Department of ENT Head and Neck Surgery, Faculty of Medicine and Pharmacy, Ibn Rochd University Hospital, Hassan II University, Casablanca, Morocco.
M. Mahtar
Department of ENT Head and Neck Surgery, Faculty of Medicine and Pharmacy, Ibn Rochd University Hospital, Hassan II University, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Hemangiopéricytoma (HP) is a rare, slow growing intranasal vascular tumour. Initially not very symptomatic, it is difficult to diagnose. The clinician should be alerted by a persistent unilateral nasal symptomatology and by the endoscopic appearance of a gray polypoid tumor. The diagnosis of certainty is histological, but biopsies are delicate, given the risk of hemorrhaging. The malignant potential of this tumor involves surgical removal. The pre-therapeutic assessment includes a naso-sinus scanner with iodine injection and magnetic resonance imaging (MRI). Some propose arteriography with pre-operative embolization. The reference surgical technique remains the para-latero-nasal pathway but endoscopic excisions have recently been reported.
Keywords: Hemangiopéricytoma, rhino-sinus tumor, endonasal surgery